within Pharmacolibrary.Drugs.N_NervousSystem.N05A_Antipsychotics.N05AG03_Penfluridol;

model Penfluridol
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_2C_enteral(
    weight = 70,
    F = 0.4,
    Cl = 9.527777777777778e-06,
    adminDuration = 600,
    adminMass = 40 / 1000000,
    adminCount = 1,
    Vd = 0.0225,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01,
    ka = 0.0023333333333333335,
    Tlag = 0,
    Vdp = 0.0062,
    k12 = 8.166666666666668e-07,
    k21 = 8.166666666666668e-07);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>Penfluridol</td></tr><tr><td>ATC code:</td><td>N05AG03</td></tr><td>route:</td><td>oral</td></tr>
    <tr><td>compartments:</td><td>2</td></tr>
    <tr><td>dosage:</td><td>40</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>22.5</td><td>L</td></tr>
    <tr><td>clearance:</td><td>0.49</td><td>L/h/kg</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Penfluridol is a long-acting oral diphenylbutylpiperidine antipsychotic drug primarily used for maintenance therapy in chronic schizophrenia and other psychoses. Its prolonged action allows for once-weekly dosing. Although once used in several countries, penfluridol is now less commonly prescribed due to the availability of newer antipsychotics with more favorable side-effect profiles.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for adult patients with schizophrenia after single oral doses.</p><h4>References</h4><ol><li><p>Migdalof, BH, et al., &amp; Janssen, PA (1979). Penfluridol: a neuroleptic drug designed for long duration of action. <i>Drug metabolism reviews</i> 9(2) 281–299. DOI:<a href=\"https://doi.org/10.3109/03602537908993895\">10.3109/03602537908993895</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/385274/\">https://pubmed.ncbi.nlm.nih.gov/385274</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.N.N05AG03 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end Penfluridol;
